Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

Clinical trial NCT06180863 · WITHDRAWN

Trial details

NCT number: NCT06180863
Sponsor: Yale University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2023-11-01
Primary completion: 2028-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.